This new diabetes pill burns fat without the downsides of Ozempic
Researchers have developed a new pill that treats type 2 diabetes and obesity by activating metabolism in skeletal muscle rather than suppressing appetite. Early clinical trials suggest the drug improves metabolic health without the muscle loss associated with GLP-1 medications like Ozempic.
Why it matters
This represents a potential breakthrough in pharmaceutical treatment for metabolic diseases, offering an alternative to current injectable therapies.
A newly developed pill could offer a fresh approach to treating type 2 diabetes and obesity. Early research suggests it may help lower blood sugar and increase fat burning without reducing appetite or causing muscle loss, two common concerns associated with some current weight loss medications.
The article summarizes medical research findings objectively.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in